A randomized, double blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab.
Study sites:
- UZ Antwerpen, Antwerpen
- UZ Gent, Gent
- CHU de Liège, Liège
- UCL St Luc, Brussels
- UZ Leuven, Leuven
